BioSpace News Archive

For more than a year since the global pandemic began, public temperature screenings among large numbers of people have become the norm in assessing symptoms and limiting the spread of coronavirus.

Akouos, Inc. (NASDAQ: AKUS), a precision genetic medicine company dedicated to developing potential gene therapies for individuals living with disabling hearing loss worldwide, today announced that the U.S. Food and Drug Administration (FDA) has granted both Orphan Drug Designation (ODD) and Rare Pediatric Disease Designation (RPDD) for AK-OTOF, a gene therapy intended for the treatment of otoferlin gene-mediated hearing loss.

The April 2021 issue of JNCCN—Journal of the National Comprehensive Cancer Network publishes new research from Memorial Sloan Kettering Cancer Center (MSK) and Gustave Roussy Institute, which suggests that baseline brain imaging should be considered in most patients with metastatic kidney cancer.

Zymeworks Inc. (NYSE:ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that the Company will present at the upcoming 2021 Bloom Burton Healthcare Investor Conference taking place April 20-21, 2021.

Kraken Robotics Inc. (TSX-V: PNG, OTCQB: KRKNF), Canada’s Ocean Company, is pleased to announce that President & CEO Karl Kenny will present live at VirtualInvestorConferences.com on April 15, 2021.

mPactAir99™ uses BMT NanoScreen™ technology to create functional, high performance filtration masks that are reusable and washable and engineered to balance outstanding filtration efficiency with the highest rated breathability available.

We are developing the infrastructure of a global zoonotic infectious diseases “alert shield” (ZIDAS) able to successfully manage and control the COVID-19 pandemic; and ultimately prevent future pandemics from developing. This alert shield will operate like a “nuclear shield,” designed to detect incoming nuclear warheads and destroy them before they can be deployed

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is pleased to announce that its wireless, wearable LEAF Patient Monitoring System has monitored more than 60,000 patients with over 7 million hours of use, helping to reduce the economic and human costs of pressure injuries.

The American Urological Association and the Urology Care Foundation, the official foundation of the AUA, recognized 14 researchers as recipients of the 2021 Urology Care Foundation Research Scholar Awards.

Meissa Vaccines (“Meissa”), a biotechnology company developing vaccines to prevent serious viral respiratory infections, announced today the appointment of Dr. Michael Watson to the Company’s Board of Directors.